These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 19841382)
1. High-sensitivity C-reactive protein predicts mortality but not stroke: the Northern Manhattan Study. Elkind MS; Luna JM; Moon YP; Liu KM; Spitalnik SL; Paik MC; Sacco RL Neurology; 2009 Oct; 73(16):1300-7. PubMed ID: 19841382 [TBL] [Abstract][Full Text] [Related]
2. High-sensitivity C-reactive protein and interleukin-6-dominant inflammation and ischemic stroke risk: the northern Manhattan study. Luna JM; Moon YP; Liu KM; Spitalnik S; Paik MC; Cheung K; Sacco RL; Elkind MS Stroke; 2014 Apr; 45(4):979-87. PubMed ID: 24627113 [TBL] [Abstract][Full Text] [Related]
3. C-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke study. Elkind MS; Luna JM; McClure LA; Zhang Y; Coffey CS; Roldan A; Del Brutto OH; Pretell EJ; Pettigrew LC; Meyer BC; Tapia J; White C; Benavente OR; Stroke; 2014 Mar; 45(3):707-16. PubMed ID: 24523037 [TBL] [Abstract][Full Text] [Related]
4. High-sensitivity C-reactive protein and lipoprotein-associated phospholipase A2 stability before and after stroke and myocardial infarction. Elkind MS; Leon V; Moon YP; Paik MC; Sacco RL Stroke; 2009 Oct; 40(10):3233-7. PubMed ID: 19644070 [TBL] [Abstract][Full Text] [Related]
5. Association Between High-Sensitivity C-Reactive Protein and Prognosis in Different Periods After Ischemic Stroke or Transient Ischemic Attack. Wang Y; Li J; Pan Y; Wang M; Meng X; Wang Y J Am Heart Assoc; 2022 Jul; 11(13):e025464. PubMed ID: 35766270 [TBL] [Abstract][Full Text] [Related]
6. C-reactive protein and homocysteine predict long-term mortality in young ischemic stroke patients. Naess H; Nyland H; Idicula T; Waje-Andreassen U J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e435-40. PubMed ID: 23735372 [TBL] [Abstract][Full Text] [Related]
7. Stroke location and association with fatal cardiac outcomes: Northern Manhattan Study (NOMAS). Rincon F; Dhamoon M; Moon Y; Paik MC; Boden-Albala B; Homma S; Di Tullio MR; Sacco RL; Elkind MS Stroke; 2008 Sep; 39(9):2425-31. PubMed ID: 18635863 [TBL] [Abstract][Full Text] [Related]
9. Residual Inflammatory Risk Predicts Poor Prognosis in Acute Ischemic Stroke or Transient Ischemic Attack Patients. Li J; Pan Y; Xu J; Li S; Wang M; Quan K; Meng X; Li H; Lin J; Wang Y; Zhao X; Liu L; Wang Y; Stroke; 2021 Aug; 52(9):2827-2836. PubMed ID: 34281380 [TBL] [Abstract][Full Text] [Related]
10. PR interval prolongation in coronary patients or risk equivalent: excess risk of ischemic stroke and vascular pathophysiological insights. Chan YH; Hai JJ; Lau KK; Li SW; Lau CP; Siu CW; Yiu KH; Tse HF BMC Cardiovasc Disord; 2017 Aug; 17(1):233. PubMed ID: 28836952 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Combined C-Reactive Protein, Body Mass Index, and Left Ventricular Ejection Fraction in Predicting Cardiovascular Events in Patients ≥80 Years of Age With Acute Myocardial Infarction. Zhang M; Liu SL; Liu HH; Liu G; Dong Q; Li JJ Am J Cardiol; 2019 Feb; 123(4):544-548. PubMed ID: 30538036 [TBL] [Abstract][Full Text] [Related]
12. Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial. Mani P; Puri R; Schwartz GG; Nissen SE; Shao M; Kastelein JJP; Menon V; Lincoff AM; Nicholls SJ JAMA Cardiol; 2019 Apr; 4(4):314-320. PubMed ID: 30840024 [TBL] [Abstract][Full Text] [Related]
15. Serum albumin levels are associated with cardioembolic and cryptogenic ischemic strokes: Northern Manhattan Study. Xu WH; Dong C; Rundek T; Elkind MS; Sacco RL Stroke; 2014 Apr; 45(4):973-8. PubMed ID: 24549868 [TBL] [Abstract][Full Text] [Related]
16. The role of very high high-sensitivity C-reactive protein levels on mortality after stroke. Itrat A; Griffith SD; Alam S; Thompson N; Katzan IL J Neurol Sci; 2017 Jan; 372():1-5. PubMed ID: 28017191 [TBL] [Abstract][Full Text] [Related]
17. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Ridker PM; Danielson E; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Macfadyen JG; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ; Lancet; 2009 Apr; 373(9670):1175-82. PubMed ID: 19329177 [TBL] [Abstract][Full Text] [Related]
18. Subclinical Cerebrovascular Disease Increases the Risk of Incident Stroke and Mortality: The Northern Manhattan Study. Wright CB; Dong C; Perez EJ; De Rosa J; Yoshita M; Rundek T; DeCarli C; Gutierrez J; Elkind MSV; Sacco RL J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28847914 [TBL] [Abstract][Full Text] [Related]
19. Joint Effect of Carotid Plaque and C-Reactive Protein on First-Ever Ischemic Stroke and Myocardial Infarction? Eltoft A; Arntzen KA; Wilsgaard T; Hansen JB; Mathiesen EB; Johnsen SH J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29773576 [TBL] [Abstract][Full Text] [Related]
20. Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study. Sacco RL; Anand K; Lee HS; Boden-Albala B; Stabler S; Allen R; Paik MC Stroke; 2004 Oct; 35(10):2263-9. PubMed ID: 15345803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]